secwatch.observer — SEC 8-K summary
======================================

Issuer:     Turn Therapeutics Inc. (TTRX)
CIK:        0002023016
Form:       8-K
Filed at:   2026-07-28T12:05:26+00:00
Accession:  0001213900-26-081996
Event type: other_material
Sentiment:  neutral
Materiality: 0.20
Item codes: 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Turn Therapeutics releases updated investor presentation; no specific details provided
--------------------------------------------------------------------------------

- Filed under Item 7.01 Regulation FD; presentation dated July 28, 2026.
- Exhibit 99.1 is the investor presentation, but its content was not included in the filing text.
- No financial results, pipeline updates, or material events disclosed in the 8-K body.
- Ticker TTRX; presentation may contain corporate overview and strategy.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/2023016/000121390026081996/0001213900-26-081996-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/2023016/000121390026081996/ea0299413-8k_turn.htm
  HTML page:      https://secwatch.observer/filing/0001213900-26-081996

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer